May 26, 2020
(Updated; originally posted April 16, 2020) The CPQA Program is continuing to provide regular services during the emergency response period. Please note that CPQA will provide an expedited review on an as-needed basis for AVRs and SOPs that support COVID-19 related research protocols.
Due to the emergency response regarding COVID-19, the CPQA has suspended all in-laboratory operations, including the shipment of proficiency testing materials for Round 45. The situation is being monitored closely and decisions to resume regular in-laboratory operations and shipment of Round 45 Proficiency Testing materials will be made accordingly.
All other CPQA programs and services remain operational, including the AVR/SOP Peer Review Program, the CPQA online tutorials for Clinical Pharmacology Study Conduct and for Bioanalytical Method Validation, and the CPQASupport email mechanism.
Please share this notice widely and contact CPQA Support with any questions or concerns.